8 31

Cited 0 times in

Cited 0 times in

Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20-17/KM23 trial

Authors
 Lee, Kyoungmin  ;  Lee, Kyung-Hun  ;  Kim, Dong-Wan  ;  Yoon, Jeesun  ;  Choi, Yoon Ji  ;  Lee, Soohyeon  ;  Kim, Ju Won  ;  Park, Kyong Hwa  ;  Choi, Wonyoung  ;  Lee, Youngjoo  ;  Ryu, Hyewon  ;  Koo, Dong-Hoe  ;  Lee, Yungyoo  ;  Jeung, Hei-Cheul  ;  Lee, Min-Young  ;  Lee, Namsu  ;  Kang, Myoung Joo  ;  Lee, Jieun  ;  Hong, Sook Hee  ;  Kang, Eun Joo  ;  Park, In Hae 
Citation
 CANCER COMMUNICATIONS, Vol.45(7) : 841-845, 2025-07 
Journal Title
CANCER COMMUNICATIONS
ISSN
 2523-3548 
Issue Date
2025-07
Abstract
[No abstract available]
Files in This Item:
88390.pdf Download
DOI
10.1002/cac2.70026
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Jeung, Hei Cheul(정희철) ORCID logo https://orcid.org/0000-0003-0952-3679
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/208633
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links